In a nutshell This study investigated the effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients with early stage peritoneal metastasis (PM; when the cancer spreads to the abdominal lining). Researchers suggested that HIPEC may benefit these patients. Some background The peritoneal region is the second...
Read More
In a nutshell This study examined the risk of recurrence following early-stage non-small cell lung cancer (NSCLC) treated with surgery. The authors showed that the risk of relapse after surgery changes in a predictable way over time, where the first two years after surgery has the highest risk of relapse. They noted that the risk then declines but...
Read More
In a nutshell This trial examined whether bevacizumab (Avastin) is a safe and effective drug for treating patients with advanced NSCLC. The authors concluded that despite varying treatment lengths and dosage, the use of bevacizumab results in an increased overall survival. Some background Bevacizumab is an anti-cancer treatment that blocks the...
Read More
Are there any immunotherapy approaches currently available to advanced prostate cancer patients? Patient Power Founder and Host, Andrew Schorr, leads a discussion with prostate cancer experts Dr. William Catalona of Lurie Cancer Center and Dr. Russell Szmulewitz on immunotherapy research. Dr. Szmulewitz gives a short account of immunology...
Read More
In a nutshell This study examined the long-term recovery rates from urinary incontinence (UI) and erectile dysfunction (ED) for men with prostate cancer treated with surgery. Researchers concluded that men with UI or ED 12 months after prostate surgery have a high chance of late recovery. Some background Prostate surgery is one of the treatment...
Read More
In a nutshell This study investigated the predictive factors for the outcomes of stage 3b melanoma. Researchers suggested that patients older than 50 years old, with tumors thicker than 2 mm and positive pelvic lymph nodes are more at risk of death by stage 3b melanoma. Some background The incidence of melanoma has been rising worldwide....
Read MoreIn a nutshell This study investigated the effectiveness of ipilimumab (Yervoy) in patients with stage 3 melanoma with high risk of recurrence (when cancer comes back). Researchers suggested that ipilimumab (at a dose of 10mg/kg) significantly increased survival of these patients. Some background Ipilimumab is an antibody that helps the...
Read More
In a nutshell This study investigated the effects of CAPOX chemotherapy (oxaliplatin plus capecitabine) or capecitabine (Xeloda) alone on survival of elderly stage 3 colon cancer patients. Researchers suggested that both CAPOX or capecitabine alone were associated with an improved survival. Some background Chemotherapy is the standard...
Read More
In a nutshell This study investigated the effectiveness of uracil-tegafur and leucovorin (UFT/LV) treatment of liver metastasis (when the cancer spread to the liver) in colorectal cancer patients. Researchers suggested that UFT/LV is an effective and safe option for the treatment of liver metastasis after liver surgery. Some background The...
Read More
In a nutshell This study examined the benefit of adding chemotherapy to androgen deprivation therapy (ADT) early to treat metastatic hormone-sensitive prostate cancer. Researchers reported a survival benefit when chemotherapy was added to ADT. This benefit was only detected with chemotherapy involving docetaxel (Taxotere). Some background ADT is a...
Read More
In a nutshell This study compared the safety and effectiveness of external beam radiation therapy (EBRT) and hypofractioned EBRT (H-EBRT) for localized prostate cancer. Researchers reported no differences in survival or disease recurrence rates between high H-EBRT and EBRT. Some background Radiation therapy is a common treatment for localized...
Read More
In a nutshell This study aimed to determine whether a certain cancer type would affect the rate of survival after limited resection in patients with early stage non-small cell lung cancer (NSCLC). The authors concluded that limited resection is beneficial for patients with adenocarcinoma but they advise caution for patients with squamous cell carcinoma...
Read More
